Novocure’s $400 Million Multi-Tranche Non-Dilutive Debt Financing

Leila Ahmed
Tagged:

Fenwick & West represented Pharmakon Advisors in the transaction.Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now